COVID-19 PANDEMIC-A FORTUNATE SCENARIO FOR PHARMACEUTICAL SCIENTISTS
AbstractCovid-2019: The pandemic that shook the entire world. There is no sarcasm if one says there will be a Pre and Post- COVID-19 world. Worldwide, millions of cases have been identified, and heaps have died. So many nations worldwide have issued a lockdown to stop the coronavirus’s unfolding, which triggered giant financial fallout. Like each and every incident has two dimensions, Covid-19 possesses both positive and negative aspects. This unfortunate pandemic’s positive aspect has been a fortunate scenario for many sectors, including pharmaceutical scientists all over the world, who are striving their best to discover antibodies that can fight the novel coronavirus. This review article mainly aims to study how this deadly pandemic has become a fortunate scenario for pharmaceutical scientists based on the data gathered (sources: websites, web blogs, reports on the internet study, newspapers, etc.). But there are some positive aspects, such as reducing pollution, reducing traffic accidents, and recognizing the importance of sanitation, hygiene, and social distancing. This pandemic revealed that there is a need to improve healthcare systems and clinical research. The pandemic situation has been a boon to the positive aspects of the pharma industry globally.
Article Information
14
5300-5307
860 KB
448
English
IJPSR
K. Swapna * and Y. Padhmanabha Reddy
Department of Pharmaceutical Analysis, Raghavendra Institute of Pharmaceutical Education and Research (RIPER) – Autonomous, K. R. Palli Cross, Anantapuramu, Andhra Pradesh, India.
swapnakandlapalli97@gmail.com
16 June 2021
28 July 2021
21 August 2021
10.13040/IJPSR.0975-8232.12(10).5300-07
01 October 2021
Download